Clinical Trials Directory

Trials / Completed

CompletedNCT00572975

Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea

MALABSORPTION BLOOD TEST: Toward a Novel Approach to Quantify Steatorrhea

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Accepted

Summary

\*The purpose of this study is to develop a more accurate, reliable, specific and more acceptable alternative clinical test to the 72-hour stool and diet collection for quantifying fat malabsorption in people with CF and pancreatic insufficiency.

Detailed description

* Nine subjects with CF will be recruited to complete the MBT on two separate occasions, with different doses of pancreatic enzymes * At each MBT visit, subjects will receive a specific enzyme dose just before they drink the test meal (shake) * Fat absorption is maximized when the enzymes are taken with the shake. * If subjects usually receive brands of pancreatic enzymes different from Creon, their dose will be converted to an equivalent dose of Creon 20 for the study. Prior to each study visit all subjects will be required to: * Eat their usual diet for 2 days prior to MBT * Refrain from consuming alcohol or dairy products for 24 hours prior to MBT * Refrain from non-routine physical exercise for 20 hours prior to MBT * Adhere to a 12-hour fast prior to MBT (from 8 PM previous night) * Can drink water from 8:00 PM on the night before the test to 2:00 AM on the day of the test * At visits 1 and 2, blood samples will be obtained at hourly intervals over a period of eight hours. * Samples will be analyzed for PA, HA and Triglyceride concentrations. * Patients will be permitted to ingest non-caloric and non-caffeinated beverages. * At hour 6, patients will be provided 1000 Kcal, low fat (12 grams of fat) lunch meal.

Conditions

Interventions

TypeNameDescription
OTHERPentadecanoic acid (PA) and Triheptadecanoin (THA)Two fats (Pentadecanoic acid and Triheptadecanoin) are administered in a breakfast shake for the purposes of determining malabsorption. in breakfast shake x1

Timeline

Start date
2006-08-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-12-13
Last updated
2008-09-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00572975. Inclusion in this directory is not an endorsement.